Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.6 EUR | -3.14% | -9.05% | -19.40% |
May. 15 | BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction | |
May. 15 | Bastide: 8.2% increase in quarterly sales | CF |
Sales 2024 * | 529M 574M | Sales 2025 * | 560M 607M | Capitalization | 160M 174M |
---|---|---|---|---|---|
Net income 2024 * | 16M 17.35M | Net income 2025 * | 22M 23.86M | EV / Sales 2024 * | 0.93 x |
Net Debt 2024 * | 333M 362M | Net Debt 2025 * | 328M 355M | EV / Sales 2025 * | 0.87 x |
P/E ratio 2024 * |
9.46
x | P/E ratio 2025 * |
7
x | Employees | 3,635 |
Yield 2024 * |
2.18% | Yield 2025 * |
2.66% | Free-Float | 44.91% |
1 day | -3.14% | ||
1 week | -9.05% | ||
1 month | +20.00% | ||
3 months | +17.39% | ||
6 months | -11.84% | ||
Current year | -19.40% |
Managers | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Corporate Officer/Principal | 50 | 15-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Vanessa Giraud
BRD | Director/Board Member | 50 | - |
Olivier Mares
BRD | Director/Board Member | 47 | 19-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 21.6 | -3.14% | 4,483 |
24-05-30 | 22.3 | -1.98% | 9,075 |
24-05-29 | 22.75 | -0.22% | 7,208 |
24-05-28 | 22.8 | -0.87% | 7,600 |
24-05-27 | 23 | -3.16% | 12,543 |
Real-time Euronext Paris, May 31, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.40% | 174M | |
-4.11% | 2.98B | |
-.--% | 1.93B | |
+23.65% | 1.86B | |
+69.11% | 707M | |
-11.21% | 461M | |
-47.58% | 298M | |
-16.45% | 131M | |
+1.92% | 67.77M |
- Stock Market
- Equities
- BLC Stock